Hyperprolactinaemia, drug-induced

Endpoint Browser PheWeb

E4_HYPERPRO_ADVERSE

No definition available.

Endpoint definition

↥

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector

Check pre-conditions, main-only, mode, registry filters

Hospital discharge: ATC codes for adverse effects of drugs ANY

Hospital Discharge: ICD-10 E22.1#

1 out of 7 registries used, show all original rules.

174

diagram downward connector

Check minimum number of events None

174

diagram downward connector

Include endpoints None

174

diagram downward connector

diagram downward connector

Remove individuals based on genotype QC

169

diagram downward connector

E4_HYPERPRO_ADVERSE

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF5

Parent code in ICD-10 E22

Name in latin Hyperprolactinaemia

NAME	E4_HYPERPRO_ADVERSE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC	ANY
HD_ICD_10	E221
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Show upset plot detailing case counts by codes

Or the full data table

Similar endpoints

↥

List of similar endpoints to Hyperprolactinaemia, drug-induced based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	169	146	23
Unadjusted prevalence (%)	0.04	0.06	0.01
Mean age at first event (years)	39.07	37.06	51.84

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_HYPERPRO_ADVERSE – Hyperprolactinaemia, drug-induced
GWS hits:

Survival analyses between endpoints

↥

Plot

before Hyperprolactinaemia, drug-induced
after Hyperprolactinaemia, drug-induced

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Hyperprolactinaemia, drug-induced

↥

Endpoint not on priority list, no data to show.